tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Schwartz, 39 are a HOLD (15.66%), 204 are a BUY (81.93%), 6 are a SELL (2.41%).
Analyst Joseph Schwartz, currently employed at LEERINK, carries an average stock price target met ratio of 59.57% that have a potential upside of 52.63% achieved within 336 days.
Joseph Schwartz’s has documented 504 price targets and ratings displayed on 47 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on TVTX, Travere Therapeutics at 11-Oct-2024.
Analyst best performing recommendations are on LRMR (LARIMAR THERAPEUTICS).
The best stock recommendation documented was for LRMR (LARIMAR THERAPEUTICS) at 12/1/2015. The price target of $132 was fulfilled within 1 day with a profit of $59.16 (30.95%) receiving and performance score of 309.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$13.75
$14
4 years 6 months 12 days ago
(05-Oct-2020)
13/18 (72.22%)
$0.67 (5.12%)
50
Buy
$13.75
$14
4 years 6 months 15 days ago
(02-Oct-2020)
5/7 (71.43%)
$0.01 (0.07%)
130
Hold
$10
$-3.75 (-27.27%)
$13
4 years 7 months 30 days ago
(18-Aug-2020)
6/8 (75%)
$-0.63 (-5.93%)
126
Buy
$10
$-3.75 (-27.27%)
$14
4 years 7 months 30 days ago
(18-Aug-2020)
1/5 (20%)
$-0.63 (-5.93%)
6
Hold
4 years 8 months 10 days ago
(07-Aug-2020)
0/3 (0%)
$17.19 (61.81%)
What Year was the first public recommendation made by Joseph Schwartz?
